Pharmos Completes Phase 1 Study of Topical Diclofenac NanoEmulsion Cream
14th Nov 2006, 18:03 GMT
Data Indicate Positive Results Achieved on Safety, Tolerability and Pharmacokinetics
Pharmos Completes Phase 1 Study of Topical Diclofenac NanoEmulsion Cream related news:
- Corcept Therapeutics Completes Enrollment In Third Phase 3 Study For Treating Psychotic Major Depression — Health News from Medical News Today
- MEDAL: Etoricoxib Shows Same Thrombotic Cardiovascular Risk as Diclofenac — Medscape Cardiology Headlines
- Off Topic — Good Morning Silicon Valley
- Turkey Hill's all-ice cream blog — Slashfood
- Anti-TNF Golimumab (CNTO 148) Continues To Show Promise In Phase 2 Rheumatoid Arthritis Study — Health News from Medical News Today
- New Study Shows ACTEMRA(TM) (tocilizumab) Significantly Improves Remission Rates In Patients With Rheumatoid Arthritis — Health News from Medical News Today
- Advanced Viral Research Files an Amendment to its Existing IND to Include Topical and Intralesional Therapy — Bio-Technology News from StratCenter.com
- Camel ice cream can help trim waistlines — IOL: A Step Beyond
- Cream Minerals Ltd.: Cream Minerals Reports Kimberlite Dykes in Area of Casierra Licences, Sierra Leone — Market Wire - Manufacturing and Production
- Results Mixed on Merck's New Painkiller — Sci-Tech Today